| Amberly Delane Caudillo, LPN | |
|
3400 W 16th St Ste P, Greeley, CO 80634-6871 | |
| (970) 978-4386 | |
| Not Available |
| Full Name | Amberly Delane Caudillo |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 3400 W 16th St Ste P, Greeley, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205400306 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 225155 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amberly Delane Caudillo, LPN 3400 W 16th St Ste P, Greeley, CO 80634-6871 Ph: (970) 978-4386 | Amberly Delane Caudillo, LPN 3400 W 16th St Ste P, Greeley, CO 80634-6871 Ph: (970) 978-4386 |
News Archive
IsoRay, Inc. (Amex: ISR) announced today that on August 5, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, Dr. David Kutler of the Department of Otorhinolaryngology, and Dr. Jason Spector of the Department of Plastic Surgery at Weill Cornell Medical Center performed the world's first Cesium-131 implant for a recurrent head and neck cancer (buccal mucosa).
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced that the Radiological Devices Panel (Panel) of the U.S. Food and Drug Administration (FDA) today unanimously voted that Hologic's Pre-Market Approval (PMA) demonstrated both the effectiveness and safety of the Company's Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system, "Selenia Dimensions 3-D."
Researchers at the Polish Academy of Sciences in Warsaw have identified a substrain of the recently emerged B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may confer resistance to antibody neutralization.
Vaginal delivery for early preterm fetuses presenting head first, or vertex presentation, had a high rate of success with no difference in neonatal mortality compared to cesarean delivery, a new study published in the American Journal of Obstetrics and Gynecology reports. For breech births, however, the failure rate of vaginal delivery was high and planned cesarean delivery was associated with significantly lower neonatal mortality.
› Verified 2 days ago